Stay updated on Moderna Press Releases

Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Moderna Press Releases page

  1. Check
    today
    Change Detected
    Summary
    The page adds an updated stock quote ($61.82) and trading volume (4.55M) and includes a new press release headline dated July 16, 2026 announcing the first participant dosed in a Phase 1 trial evaluating an investigational tumor-targeted cancer antigen therapy in solid tumors.
    Difference
    1%
    Check dated 2026-07-18T09:16:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added: Q2 2026 financial results announcement, appointment of Michael McDonnell to Moderna's Board of Directors, and updated stock data (price 68.27, volume 9.18M) with dates July 9 and 8, 2026. Removed: the prior stock price (79.76) and two May 2026 press releases (TIME recognition and NEJM publication).
    Difference
    5%
    Check dated 2026-07-11T06:24:19.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Moderna's header stock quote updated to $79.76 with a volume of 14.11M, replacing the previous $67.27 and 14.45M. This update provides the latest market data accompanying the press releases page.
    Difference
    0.5%
    Check dated 2026-07-04T03:50:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows updated stock data ($67.27, 14.45M) and adds a June 25, 2026 press release titled 'Moderna Science Day Highlights Expanding Potential of mRNA Platform'; the May 1, 2026 stock data and the 'Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates' entry were removed.
    Difference
    1%
    Check dated 2026-06-26T23:09:40.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    New press releases were added, including FDA advisory committee votes on mRNA-1010 and an investor Science Day, plus organizational changes for launches; older press releases were removed.
    Difference
    5%
    Check dated 2026-06-19T17:57:43.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Stock data moved from $49.25 with 944.86K volume to $51.03 with 1.71M, and a new press release announcing UK authorization to begin a Phase 1/2 study of a Lynch Syndrome mRNA cancer vaccine (dated June 8, 2026) was added. The page also removes the older stock figures and the May 2026 conference post (April 21, 2026).
    Difference
    1%
    Check dated 2026-06-12T15:52:08.000Z thumbnail image

Stay in the know with updates to Moderna Press Releases

Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.